Fig 1.
Legend IQR, interquartile range.
Table 1.
Prisoner baseline characteristics.
Table 2.
Results of cirrhosis determination using APRI, FIB-4 and elastography.
Table 3.
Accuracy of APRI and FIB4 in predicting cirrhosis as compared to transient elastography.
Table 4.
Performance of age categories for predicting cirrhosis as compared to transient elastography.
Table 5.
Performance of APRI in different age categories for predicting cirrhosis as compared to transient elastography.
Fig 2.
A novel clinical pathway for fibrosis assessment prior to HCV treatment in prisons.
This pathway achieves a NPV for cirrhosis of >95% in all prisoners and minimises the need for FibroScan by 78%.